Treace Medical Concepts, Inc.
TMCI
$6.74
-$0.255-3.65%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -501.00K | -15.36M | -21.21M | -18.68M | -6.28M |
| Total Depreciation and Amortization | 1.24M | 2.16M | 2.12M | 1.91M | 1.27M |
| Total Amortization of Deferred Charges | 1.08M | 74.00K | 74.00K | 75.00K | 574.00K |
| Total Other Non-Cash Items | 10.99M | 7.29M | 9.10M | 7.91M | 6.49M |
| Change in Net Operating Assets | -17.01M | -6.00M | -3.98M | 1.56M | -1.52M |
| Cash from Operations | -4.21M | -11.84M | -13.90M | -7.22M | 532.00K |
| Capital Expenditure | -3.07M | -2.86M | -1.73M | -3.93M | -2.25M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 6.50M | 8.63M | 24.16M | 7.69M | 7.26M |
| Cash from Investing | 3.42M | 5.76M | 22.43M | 3.76M | 5.01M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 57.00K | 8.00K | 311.00K | 52.00K | 178.00K |
| Repurchase of Common Stock | -31.00K | 0.00 | 0.00 | -237.00K | -13.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Financing | 26.00K | 8.00K | 311.00K | -185.00K | 165.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -760.00K | -6.07M | 8.85M | -3.65M | 5.70M |
